(29/04/2017)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 30 | 7 | 0 / 00% | 2 / 540% | 1 / 250% | 3 / 742.9% | | 1 | 4 | 0 | 4 | 2 | 0 | 1 | 4 | 6 |
(22/04/2017)vs
LIONS / POLIS | 00 | 5 | 1 / 250% | 2 / 366.7% | 0 / 30% | 2 / 633.3% | | 1 | 5 | 4 | 9 | 6 | 2 | 0 | 2 | 15 |
(08/04/2017)vs
ΠΗΓΑΣΟΣ | 00 | 12 | 1 / 333.3% | 4 / 666.7% | 1 / 520% | 5 / 1145.5% | | 1 | 5 | 3 | 8 | 2 | 2 | 1 | 2 | 15 |
(01/04/2017)vs
ΚΑΤΣΕΛΗΣ | 00 | 4 | 0 / 00% | 2 / 540% | 0 / 20% | 2 / 728.6% | | 0 | 2 | 2 | 4 | 4 | 0 | 0 | 2 | 5 |
(25/03/2017)vs
ELNAVI | 00 | 11 | 2 / 2100% | 3 / 837.5% | 1 / 333.3% | 4 / 1136.4% | | 3 | 6 | 1 | 7 | 1 | 4 | 0 | 4 | 12 |
(18/03/2017)vs
VITEX | 00 | 2 | 0 / 00% | 1 / 333.3% | 0 / 10% | 1 / 425% | | 0 | 4 | 0 | 4 | 1 | 0 | 0 | 2 | 2 |
(12/03/2017)vs
ELNAVI | 00 | 11 | 2 / 2100% | 3 / 650% | 1 / 812.5% | 4 / 1428.6% | | 3 | 2 | 1 | 3 | 3 | 1 | 0 | 2 | 6 |
(04/03/2017)vs
MINERVA MARINE | 29 | 5 | 0 / 00% | 1 / 250% | 1 / 333.3% | 2 / 540% | | 0 | 4 | 1 | 5 | 0 | 0 | 1 | 1 | 7 |
(12/02/2017)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 00 | 0 | 0 / 00% | 0 / 00% | 0 / 00% | 0 / 00% | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
(05/02/2017)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 9 | 0 / 00% | 3 / 742.9% | 1 / 425% | 4 / 1136.4% | | 0 | 2 | 5 | 7 | 1 | 1 | 0 | 1 | 10 |
(28/01/2017)vs
LIONS / POLIS | 00 | 5 | 3 / 3100% | 1 / 333.3% | 0 / 20% | 1 / 520% | | 2 | 1 | 0 | 1 | 0 | 1 | 0 | 4 | -1 |
(21/01/2017)vs
ΠΗΓΑΣΟΣ | 00 | 3 | 0 / 00% | 0 / 30% | 1 / 250% | 1 / 520% | | 0 | 4 | 0 | 4 | 0 | 0 | 1 | 1 | 3 |
(04/12/2016)vs
MINERVA MARINE | 26 | 5 | 0 / 00% | 1 / 425% | 1 / 425% | 2 / 825% | | 1 | 6 | 0 | 6 | 1 | 0 | 0 | 1 | 5 |
(19/11/2016)vs
VITEX | 00 | 3 | 1 / 250% | 1 / 520% | 0 / 00% | 1 / 520% | | 2 | 5 | 0 | 5 | 3 | 0 | 1 | 1 | 6 |
(05/11/2016)vs
ΣΥΛ. ΠΑΛ. ΕΣΠΕΡΟΥ | 18 | 4 | 2 / 2100% | 1 / 425% | 0 / 30% | 1 / 714.3% | | 3 | 3 | 1 | 4 | 0 | 0 | 0 | 3 | -1 |
(22/10/2016)vs
VITEX | 30 | 6 | 0 / 00% | 3 / 742.9% | 0 / 10% | 3 / 837.5% | | 1 | 4 | 4 | 8 | 2 | 1 | 0 | 3 | 9 |
(09/10/2016)vs
ΣΥΛ. ΠΑΛ. ΕΣΠΕΡΟΥ | 00 | 3 | 1 / 250% | 1 / 520% | 0 / 10% | 1 / 616.7% | | 0 | 2 | 0 | 2 | 2 | 2 | 0 | 1 | 2 |
(03/10/2016)vs
BIOMEGA | 20 | 2 | 0 / 00% | 1 / 250% | 0 / 10% | 1 / 333.3% | | 0 | 4 | 0 | 4 | 0 | 2 | 0 | 1 | 5 |
| ΣΥΝΟΛΙΚΑ |
153 |
97 |
13 / 1872.2% |
30 / 7838.5% |
8 / 4517.8% |
38 / 12330.9% |
|
18 |
63 |
22 |
85 |
28 |
16 |
5 |
35 |
106 |
| ΜΕΣΟΙ ΟΡΟΙ |
8.5 |
5.4 |
0.7 / 172.2% |
1.7 / 4.338.5% |
0.4 / 2.517.8% |
2.1 / 6.830.9% |
|
1 |
3.5 |
1.2 |
4.7 |
1.6 |
0.9 |
0.3 |
1.9 |
5.9 |